Merck to structure itself into 5 units following close of $41.1 billion Schering-Plough deal

Merck to form 5 divisions after Schering buyout

NEW YORK — Richard T. Clark, current president and CEO of Merck, says the company will restructure into five divisions after it completes the buyout of rival Schering-Plough for $41.1 billion.

Clark will remain CEO of the new company. The deal is expected to close in the fourth quarter.

The new company will have five primary divisions, including Global Human Health, Animal Health, Consumer Health Care, Merck Research Laboratories, and Merck Manufacturing.

Also, the Whitehouse Station, N.J., company says about 40 percent of Schering-Plough’s senior leaders will be part of the newly combined company in executive roles, while a substantial majority of that company’s employees will remain with the combined company.